Date Posted: Apr 17, 2019
Application Deadline: Open Until Filled
The Kadara laboratory in the Department of Translational Molecular Pathology at The University of Texas MD Anderson Cancer Center (MD Anderson) has an opening for a postdoctoral fellow (PhD, MD or MD/PhD) in cancer immunology. The group is actively engaged in understanding the evolution of the host immune contexture in the phenotypic development of lung cancers particularly those with somatic activating mutations in the KRAS oncogene. The candidate postdoctoral fellow will also be engaged in interrogating the role of genomic, immunogenomic and immune cues in the development of lung preneoplasia and their progression to malignancy. In delivering these goals, the laboratory uses genetically modified human-relevant mouse models with tobacco carcinogen exposure as well as human tissue specimens in collaboration with various investigators at MD Anderson and other institutes. The postdoctoral fellow will have the opportunity to interact with a multidisciplinary team of basic scientists, physicians and physician scientists in various fields including cancer biology, carcinogenesis, prevention, genomics, immunogenomics and bioinformatics. The candidate must have obtained their terminal degree within the past year, or are near graduation. Candidates must have formal training in immunology and/or cancer immunology. Excellent scientific writing and presentation skills are highly encouraged.
Interested candidates should send their CV and list of three references with their contact information to Dr. Humam Kadara (firstname.lastname@example.org).
M. D. Anderson Cancer Center is an equal opportunity employer and does not discriminate on basis of race, color, national origin, gender, sexual orientation, age, religion, disability or veteran status except where such distinction is required by law. All positions at The University of Texas M. D. Anderson Cancer Center are security sensitive and subject to examination of criminal history record information. Smoke-free and drug-free environment.